Suppr超能文献

多能干细胞在免疫缺陷小鼠中重现人类婴儿血管瘤。

Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

作者信息

Khan Zia A, Boscolo Elisa, Picard Arnaud, Psutka Sarah, Melero-Martin Juan M, Bartch Tatianna C, Mulliken John B, Bischoff Joyce

机构信息

Vascular Biology Program and Department of Surgery, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Clin Invest. 2008 Jul;118(7):2592-9. doi: 10.1172/JCI33493.

Abstract

Infantile hemangioma is a benign endothelial tumor composed of disorganized blood vessels. It exhibits a unique life cycle of rapid postnatal growth followed by slow regression to a fibrofatty residuum. Here, we have reported the isolation of multipotential stem cells from hemangioma tissue that give rise to hemangioma-like lesions in immunodeficient mice. Cells were isolated based on expression of the stem cell marker CD133 and expanded from single cells as clonal populations. The CD133-selected cells generated human blood vessels 7 days after implantation in immunodeficient mice. Cell retrieval experiments showed the cells could again form vessels when transplanted into secondary recipients. The human vessels expressed GLUT-1 and merosin, immunodiagnostic markers for infantile hemangioma. Two months after implantation, the number of blood vessels diminished and human adipocytes became evident. Lentiviral expression of GFP was used to confirm that the hemangioma-derived cells formed the blood vessels and adipocytes in the immunodeficient mice. Thus, when transplanted into immunodeficient mice, hemangioma-derived cells recapitulated the unique evolution of infantile hemangioma--the formation of blood vessels followed by involution to fatty tissue. In summary, this study identifies a stem cell as the cellular origin of infantile hemangioma and describes for what we believe is the first time an animal model for this common tumor of infancy.

摘要

婴儿血管瘤是一种由紊乱的血管组成的良性内皮肿瘤。它呈现出独特的生命周期,出生后迅速生长,随后缓慢消退为纤维脂肪残余物。在此,我们报告了从血管瘤组织中分离出多能干细胞,这些细胞在免疫缺陷小鼠中可形成血管瘤样病变。细胞基于干细胞标志物CD133的表达进行分离,并从单细胞扩增为克隆群体。CD133选择的细胞在植入免疫缺陷小鼠7天后生成了人血管。细胞取回实验表明,这些细胞再次移植到二级受体中时能够再次形成血管。人血管表达GLUT-1和merosin,这是婴儿血管瘤的免疫诊断标志物。植入两个月后,血管数量减少,人脂肪细胞变得明显。利用慢病毒表达绿色荧光蛋白(GFP)来证实血管瘤来源的细胞在免疫缺陷小鼠中形成了血管和脂肪细胞。因此,当移植到免疫缺陷小鼠中时,血管瘤来源的细胞重现了婴儿血管瘤独特的演变过程——血管形成后再退化至脂肪组织。总之,本研究确定了一种干细胞是婴儿血管瘤的细胞起源,并首次描述了这种常见婴儿肿瘤的动物模型。

相似文献

6
Progenitor cells in infantile hemangioma.婴儿血管瘤中的祖细胞。
J Craniofac Surg. 2009 Mar;20 Suppl 1(Suppl 1):695-7. doi: 10.1097/SCS.0b013e318193d6ac.
7
Vasculogenesis in infantile hemangioma.婴儿血管瘤中的血管生成
Angiogenesis. 2009;12(2):197-207. doi: 10.1007/s10456-009-9148-2. Epub 2009 May 10.

引用本文的文献

9
Recent Advances in Targeted Therapies for Infantile Hemangiomas.婴幼儿血管瘤靶向治疗的最新进展。
Int J Nanomedicine. 2024 Jun 19;19:6127-6143. doi: 10.2147/IJN.S463119. eCollection 2024.
10
Congenital Vascular and Lymphatic Diseases.先天性血管和淋巴管疾病。
Circ Res. 2024 Jun 21;135(1):159-173. doi: 10.1161/CIRCRESAHA.124.323181. Epub 2024 Jun 20.

本文引用的文献

1
A novel in vivo model of human hemangioma: xenograft of human hemangioma tissue on nude mice.
Plast Reconstr Surg. 2007 Sep 15;120(4):869-878. doi: 10.1097/01.prs.0000277661.49581.c9.
4
Identification and expansion of human colon-cancer-initiating cells.人结肠癌起始细胞的鉴定与扩增。
Nature. 2007 Jan 4;445(7123):111-5. doi: 10.1038/nature05384. Epub 2006 Nov 19.
7
The pathogenesis of hemangiomas: a review.
Plast Reconstr Surg. 2006 Feb;117(2):29e-35e. doi: 10.1097/01.prs.0000197134.72984.cb.
8
Mesenchymal stem cells and adipogenesis in hemangioma involution.间充质干细胞与血管瘤消退中的脂肪生成
Stem Cells. 2006 Jun;24(6):1605-12. doi: 10.1634/stemcells.2005-0298. Epub 2006 Feb 2.
9
Myeloid cells in infantile hemangioma.婴儿血管瘤中的髓样细胞。
Am J Pathol. 2006 Feb;168(2):621-8. doi: 10.2353/ajpath.2006.050618.
10
Evidence by molecular profiling for a placental origin of infantile hemangioma.通过分子谱分析证明婴儿血管瘤起源于胎盘。
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19097-102. doi: 10.1073/pnas.0509579102. Epub 2005 Dec 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验